Publicidad
Caso clínico 29 de agosto de 2012

Alteración de la perfusión, desplazamiento del ST y arritmias en paciente con espasmo coronario sin lesiones significativas

Referenciar Imprimir Descargar PDF

Referencias

  1. Prinzmetal M, Kennamer R, Merliss R, et al: Angina pectoris. I. A variant form of angina pectoris: Preliminary report: Am J Med 1959;27:375-88.
  2. Cohen M: Variant angina pectoris. In FusterV, Ross R, Topol EJ (eds): Atherosclerosis and Coronary Artery Disease. Philadelphia, Lippincott-Raven, 1996. Pp 1367-76.
  3. Coma-Canella I, Castano S, Macías A, Calabuig J, Artaiz M. Ergonovine test in angina with normal coronary arteries. Is it worth doing it? Int J Cardiol 2007;114:249-50.
  4. De Servi S, Falcone C, Gavazzi A, et al. The exercise test in variant angina: results in 114 patients. Circulation 1981;64:684–88.
  5. Aoki M, Koyanagi S, Sakai K, et al. Exercise-induced silent myocardial ischemia in patients with vasospastic angina. Am Heart J 1990;119:551–6.
  6. Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2008) – Digest Version – JCS Joint Working Group Circulation Journal. Official Journal of the Japanese Circulation Society. [Internet] disponible en: http://www.jcirc.or.jp.
  7. Okumura K, Yasue H, Matsuyama K, et al: Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholines and the dilator effects of nitroglycerin. J Am Coll Cardiol 1996;27:45-52.
  8. Cox ID, Kaski JC, Clague JR: Endothelial dysfunction in the absence or coronary atheroma causing Prinzmetal’s angina. Heart 1997;77:584.
  9. Minoda K, Yasue H, Kugiyama K, et al. Comparison of the distribution of myocardial blood flow between exercise induced and hyperventilation-induced attacks of coronary spasm: a study with thalium-201 myocardial scintigraphy. Am Heart J 1994; 127:1474-80.
  10. Tsuchiya T, Okumura K, Yasue H, et al. Heart period variability in patients with variant angina. Am J Cardiol 1996;77:932–36.
  11. Fujita H, Yamabe H, Yokoyama M. Dipyridamole-induced reversible thallium-201 defect in patients with vasospastic angina and nearly normal coronary arteries. Clin Cardiol 2000;23:24–30.
  12. Myerburg RJ, Kessler KM, Mallon SM, et al. Lifethreatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary artery spasm. N Engl J Med 1992;326:1451-5.
  13. Mc Alpin RN. Relation of coronary arterial spasm to sites of organic stenosis. Am J Cardiol 1980;46:143–53.
  14. Nakamura M, Takheshita A, Nose Y. Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina. Circulation 1987;75:1110–6.
  15. Ashikaga T, Nishizaki M, Arita M, et al. Increased QTc dispersion by Dipyridamole in patients with vasospastic angina. Circulation 1995;92:8;I–480 (abstract).